Which has grown faster, SERA or VTVT?

Over the past five years, SERA grew revenue faster — SERA at a 9.73% CAGR versus VTVT at -18.12%.

How have SERA and VTVT total returns compared?

Over the past 5 years, SERA delivered -28.91% and VTVT delivered -13.55% annualized total return. Past performance doesn't predict future results.

Sera Prognostics, Inc. (SERA) vs vTv Therapeutics Inc. (VTVT)

A side-by-side comparison of Sera Prognostics, Inc. and vTv Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

SERA

Sera Prognostics, Inc.

$78M

$2.05HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

VTVT

vTv Therapeutics Inc.

$79M

$30.03HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — SERA vs VTVT

growth of $100 · dividends reinvested · last 5y

SERA -83.2% (-30.0%/yr)VTVT -62.3% (-17.7%/yr)VTVT compounded faster over this window

SERA VTVT

SERA vs VTVT: by the numbers

•VTVT is the larger company ($79M vs $78M market cap).
•Both run net losses; VTVT's is the smaller (-12.91% vs -47475.71% net margin).
•SERA grew revenue faster over the past five years (9.73% vs -18.12% CAGR).

Metrics side by side

Valuation

Metric	SERA	VTVT
P/S ratio	1118.45	2.13
P/B ratio	1.32	1.00

Profitability

Metric	SERA	VTVT
Gross margin	-102.47%	0.00%
Operating margin	-45066.67%	0.00%
Net margin	-47475.71%	-12.91%
ROE	-55.97%	-6.05%
ROIC	-59.79%	-11.48%

Growth (annualized)

Metric	SERA	VTVT
Revenue CAGR (5Y)	9.73%	-18.12%
Total return CAGR (5Y)	-28.91%	-13.55%

Frequently asked

Which has grown faster, SERA or VTVT?: Over the past five years, SERA grew revenue faster — SERA at a 9.73% CAGR versus VTVT at -18.12%.
How have SERA and VTVT total returns compared?: Over the past 5 years, SERA delivered -28.91% and VTVT delivered -13.55% annualized total return. Past performance doesn't predict future results.

Go deeper

Full SERA analysis Full VTVT analysis Interactive comparison tool

Dig into the metrics

Sera Prognostics ROE vTv Therapeutics ROE Sera Prognostics operating margin vTv Therapeutics operating margin Sera Prognostics revenue growth vTv Therapeutics revenue growth Sera Prognostics free cash flow vTv Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.